Lv1
20 积分 2024-06-18 加入
Urine biomarkers in bladder cancer — current status and future perspectives
3个月前
已完结
First and Second-line Treatments in Metastatic Renal Cell Carcinoma
3个月前
已完结
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade
1年前
已完结
Multiple cancer cell types release LIF and Gal3 to hijack neural signals
1年前
已完结
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy
1年前
已完结
At the interface of tumor-associated macrophages and fibroblasts: immune-suppressive networks and emerging exploitable targets
1年前
已完结
皖公网安备34019202002308
